Obstetrics & Gynecology Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Obstetrics & Gynecology 2004;103:24-30
© 2004 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hackney, D. N.
Right arrow Articles by O’Shaughnessy, R. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hackney, D. N.
Right arrow Articles by O’Shaughnessy, R. W.
Related Collections
Right arrow General obstetrics
Right arrow Maternal/fetal physiology
Right arrow Obstetric complications of pregnancy
Right arrow Pediatrics/neonatology

ORIGINAL RESEARCH

Management of Pregnancies Complicated by Anti-c Isoimmunization

David N. Hackney, MD, Eric J. Knudtson, MD, Karen Q. Rossi, RN, Dave Krugh, MT(ASCP)SBB and Richard W. O’Shaughnessy, MD

From the Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, and Division of Transfusion Medicine, Department of Pathology, The Ohio State University College of Medicine and Public Health, Columbus, Ohio.

Address reprint requests to: Richard O’Shaughnessy, MD, 561 Means Hall, 1654 Upham Drive, Columbus, OH 43210-1282; e-mail: oshaughnessy.1{at}osu.edu.

OBJECTIVE: To review cases of anti-c isoimmunization and determine the most appropriate management strategies.

METHODS: We performed a review of 102 pregnancies managed at The Ohio State University from 1967 to 2001 for anti-c isoimmunization. Of these, 55 had complete data and are included in this report. Information collected included serum titers, {Delta}OD450 values, Liley zones, fetal and neonatal hemoglobin levels and antigen typing, neonatal direct antiglobulin test, and neonatal outcomes. The appropriateness of traditional management was then evaluated.

RESULTS: Of the 55 pregnancies, 46 had fetuses with positive direct antiglobulin test, and nine pregnancies had unaffected fetuses. Of the affected neonates, 12 (26%) had serious hemolytic disease of the newborn. Of these 12, 8 required fetal transfusion, and the remaining 4 newborns had hemoglobin levels of less than 10 g/dL at the time of delivery. A titer of 1:32 or greater or the presence of hydrops fetalis identified all such fetuses. There were 58 amniocenteses performed for {Delta}OD450 When plotted on modified Liley graphs, {Delta}OD450 values corresponded to disease severity. There were no perinatal deaths attributable to anti-c hemolytic disease of the newborn.

CONCLUSION: Anti-c isoimmunization might cause significant fetal and newborn hemolytic disease. A titer of 1:32 or greater or evidence of hydrops fetalis identified all the serious hemolytic disease at our institution. The significance of antibody titers and {Delta}OD450 values was similar to Rh-D sensitized pregnancies, and management by the same modalities is appropriate.

LEVEL OF EVIDENCE: II-3






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American College of Obstetricians and Gynecologists.